Jeff Brown


Penny IPOs Unlock Private-Investing Gains

Thanks to private investors “locking out” their investments, retail investors are left buying into overhyped, overvalued companies. So where have all the good investments gone? We think we’ve found the answer.

Biotech Being Used to Treat Rare Diseases

Hundreds of millions of people around the world suffer from rare diseases with no cure. But this technology means...

Genetic-Editing Has Potential to Cure Many Diseases

Back in 2019, the implications from initial trials of this new technology were outstanding. But now, this technology has...

Coronavirus Pandemic Pushes Biotech Into Overdrive

Thanks to the coronavirus, it’s been a turbulent year for equity markets. But amid all the uncertainty, the pandemic...

Pandemic Is Accelerating Biotech IPOs

Although 2020 was supposed to be the blockbuster year for IPOs, COVID-19 paused those plans. But the clouds are...

Coronavirus Boosts Investors’ Profit Potential in Small Tech Sector

The coronavirus has forced the world to adapt to society-altering changes. And these two forces are pushing this small...

We Are Entering a Golden Age of Biotech

COVID-19 has opened the door to new approaches for cures we’ve never considered before. And this is the beginning...